Page last updated: 2024-11-08

butyrylcarnitine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

butyrylcarnitine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-butanoyl-L-carnitine : An optically active form of O-butanoylcarnitine having L-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

O-butanoylcarnitine : A C4-acylcarnitine that is the O-butanoyl derivative of carnitine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID213144
CHEBI ID21949
SCHEMBL ID886918
MeSH IDM0388746

Synonyms (35)

Synonym
25576-40-3
butyrylcarnitine
ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, butyrate, l-
brn 4138519
n-butyryl-l-(-)-carnitin [german]
1-propanaminium, 3-carboxy-n,n,n-trimethyl-2-(1-oxobutoxy)-, inner salt, (r)-
butyryl-l-carnitine
l-carnitine butyryl ester
LMFA07070003
o-butanoyl-carnitine
o-butanoylcarnitine
(3r)-3-butanoyloxy-4-(trimethylazaniumyl)butanoate
n-butyryl-l-(-)-carnitin
o-butanoyl-l-carnitine
o-butanoyl-(r)-carnitine
(3r)-3-(butyryloxy)-4-(trimethylammonio)butanoate
(3r)-3-(butyryloxy)-4-(trimethylazaniumyl)butanoate
CHEBI:21949
SCHEMBL886918
3-butanoyloxy-4-trimethylammonio-butanoate
DTXSID10180266
butyryl-l-carnitine, >=97.0% (tlc)
(3-carboxy-2-hydroxypropyl)trimethyl-l-butyrate
n-butyryl-l(-)-carnitine
(r)-3-carboxy-n,n,n-trimethyl-2-(1-oxobutoxy)-1-propanaminium
ester with (3-carboxy-2-hydroxypropyl)trimethylammonium l-butyric acid
ester with l-(3-carboxy-2-hydroxypropyl)trimethylammonium butyric acid
(3r)-3-(butanoyloxy)-4-(trimethylazaniumyl)butanoate
AS-65654
Q27109418
c4butyryl-l-carnitine
HY-113168
CS-0062329
(r)-3-(butyryloxy)-4-(trimethylammonio)butanoate
AKOS037646006
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
O-butanoylcarnitineA C4-acylcarnitine that is the O-butanoyl derivative of carnitine.
saturated fatty acyl-L-carnitineAn O-acylcarnitine in which the R is a saturated fatty acyl chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (48.28)29.6817
2010's9 (31.03)24.3611
2020's6 (20.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.44 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (6.90%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.45%)4.05%
Observational0 (0.00%)0.25%
Other26 (89.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]